These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12586442)

  • 1. A new role for corticotropin-releasing factor receptor-2: suppression of vascularization.
    Bale TL; Giordano FJ; Vale WW
    Trends Cardiovasc Med; 2003 Feb; 13(2):68-71. PubMed ID: 12586442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization.
    Bale TL; Giordano FJ; Hickey RP; Huang Y; Nath AK; Peterson KL; Vale WW; Lee KF
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7734-9. PubMed ID: 12032352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti-angiogenic signaling pathways.
    Tezval H; Jurk S; Atschekzei F; Serth J; Kuczyk MA; Merseburger AS
    Prostate; 2009 Mar; 69(4):443-8. PubMed ID: 19058138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urocortin's inhibition of tumor growth and angiogenesis in hepatocellular carcinoma via corticotrophin-releasing factor receptor 2.
    Wang J; Xu Y; Xu Y; Zhu H; Zhang R; Zhang G; Li S
    Cancer Invest; 2008 May; 26(4):359-68. PubMed ID: 18443956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation.
    Hao Z; Huang Y; Cleman J; Jovin IS; Vale WW; Bale TL; Giordano FJ
    Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3939-44. PubMed ID: 18308934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure.
    Bale TL; Hoshijima M; Gu Y; Dalton N; Anderson KR; Lee KF; Rivier J; Chien KR; Vale WW; Peterson KL
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3697-702. PubMed ID: 14990799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: disruption of an endogenous inhibitor of angiogenesis and proliferation.
    Tezval H; Jurk S; Atschekzei F; Becker JU; Jahn O; Serth J; Kuczyk MA
    World J Urol; 2009 Dec; 27(6):825-30. PubMed ID: 19437022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac dynamics in corticotropin-releasing factor receptor subtype-2 deficient mice.
    Stiedl O; Meyer M
    Neuropeptides; 2003 Feb; 37(1):3-16. PubMed ID: 12637030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractal dynamics of heart beat interval fluctuations in corticotropin-releasing factor receptor subtype 2 deficient mice.
    Stiedl O; Meyer M
    Integr Physiol Behav Sci; 2002; 37(4):311-45. PubMed ID: 12645846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior.
    Bale TL; Picetti R; Contarino A; Koob GF; Vale WW; Lee KF
    J Neurosci; 2002 Jan; 22(1):193-9. PubMed ID: 11756502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.
    Wang H; Keiser JA
    Circ Res; 1998 Oct; 83(8):832-40. PubMed ID: 9776730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress-mediated heart rate dynamics after deletion of the gene encoding corticotropin-releasing factor receptor 2.
    Stiedl O; Meyer M; Kishimoto T; Rosenfeld MG; Spiess J
    Eur J Neurosci; 2003 May; 17(10):2231-5. PubMed ID: 12786991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2.
    Radulovic J; Rühmann A; Liepold T; Spiess J
    J Neurosci; 1999 Jun; 19(12):5016-25. PubMed ID: 10366634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of corticotropin releasing factor receptor type 2 in the heart by corticotropin releasing factor offers cytoprotection against ischemic injury via PKA and PKC dependent signaling.
    Jonassen AK; Wergeland A; Helgeland E; Mjøs OD; Brar BK
    Regul Pept; 2012 Feb; 174(1-3):90-7. PubMed ID: 22209828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of corticotropin releasing factor receptor 2 (CRFR2) in the human prostate. A new potential target for medical therapy of benign prostatic hyperplasia].
    Tezval H; Merseburger AS; Seidler M; Serth J; Kuczyk MA; Oelke M
    Urologe A; 2008 Sep; 47(9):1079-80, 1082-4. PubMed ID: 18670748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of mTOR in Type 2 CRF Receptor Inhibition of Insulin Signaling in Muscle Cells.
    Chao H; Li H; Grande R; Lira V; Yan Z; Harris TE; Li C
    Mol Endocrinol; 2015 Jun; 29(6):831-41. PubMed ID: 25875045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of corticotropin-releasing factor receptor 2 inhibits the growth of human small cell lung carcinoma cells.
    Wang J; Jin L; Chen J; Li S
    Cancer Invest; 2010 Feb; 28(2):146-55. PubMed ID: 19968503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotrophin-releasing factor participates in S1PR3-dependent cPLA2 expression and cell motility in vascular smooth muscle cells.
    Zhu C; Cao C; Dai L; Yuan J; Li S
    Vascul Pharmacol; 2015 Aug; 71():116-26. PubMed ID: 25869501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractal dynamics in circadian cardiac time series of corticotropin-releasing factor receptor subtype-2 deficient mice.
    Stiedl O; Meyer M
    J Math Biol; 2003 Aug; 47(2):169-97. PubMed ID: 12883860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtype-specific differences in corticotropin-releasing factor receptor complexes detected by fluorescence spectroscopy.
    Milan-Lobo L; Gsandtner I; Gaubitzer E; Rünzler D; Buchmayer F; Köhler G; Bonci A; Freissmuth M; Sitte HH
    Mol Pharmacol; 2009 Dec; 76(6):1196-210. PubMed ID: 19755522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.